Moore TJ, Mattison DR. Assessment of patterns of potentially unsafe use of zolpidem. JAMA Intern Med 2018;178:septiembre. [Ref.ID 102884]

Moore TJ, Furberg CD, Mattison DR, Cohen MR. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014. Pharmacoepidemiol Drug Saf 2016;25:713-8. [Ref.ID 100396]

Crispo JAG, Fortin Y, Thibault DP, Emons M, Bjerre LM, Kohen DE, Perez-Lloret S, Mattison DR, Willis AW, Krewski D. Trends in inpatient antiparkinson drug use in the USA, 2001-2012. Eur J Clin Pharmacol 2015;71:1011-9. [Ref.ID 99381]

Moore TJ, Glenmullen J, Mattison DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med 2014;174:1930-3. [Ref.ID 98401]

Moore TJ, Cohen MR, Mattison DR. Dabigatran, bleeding, and the regulators. BMJ 2014;349:g4517. [Ref.ID 98146]

Koren G, Clark S, Hankins GD, Caritis SN, Miodovnik M, Mattison DR. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol 2010;203:1-7. [Ref.ID 89852]

Birenbaum D, Mattison DR. Analgesics for the treatment of pain in children. The authors reply. N Engl J Med 2003;348:960. [Ref.ID 65332]

Birenbaum D, Mattison DR. Analgesics for the treatment of pain in children. N Engl J Med 2003;348:959-60. [Ref.ID 65331]

Mattison DR, Thorgeirsson SS. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet 1978;1:187-8. [Ref.ID 3810]